Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

Authors: Steven E. Lipshultz, Rebecca E. Scully, Stuart R. Lipsitz, Stephen E. Sallan, Lewis B. Silverman, Tracie L. Miller, Elly Barry, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Eric Larsen, Albert Moghrabi, Yvan Samson, Bruno Michon, Marshall A. Schorin, Harvey J. Cohen, Donna Neuberg, E. John Orav, Steven D. Colan - The Lancet 2010 cited by 447